Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

If you are wondering whether DexCom at around US$64 a share looks appealing or expensive, this article breaks down what that ...

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

Without a specific news headline driving the move, DexCom (DXCM) sits at a recent close of US$70.69, leaving investors weighing its continuous glucose monitoring business against recent share price ...

One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering gross margin profile is poised to witness an inflection point this year. As you ...